seasonal trivalent influenza vaccine including H1N1

The seasonal trivalent influenza vaccine including H1N1 is an inactivated biologic vaccine designed to prevent seasonal influenza. It contains hemagglutinin (HA) surface antigens from three WHO-recommended influenza strains: influenza A/H1N1, influenza A/H3N2, and influenza B. The vaccine works by eliciting the production of hemagglutination-inhibition (HAI) antibodies by the immune system's B-cells and T-cells. This specific formulation was evaluated by the Medizinische Hochschule Hannover in a Phase II clinical trial to assess its immunogenicity, safety, and tolerability in immunocompromised adults following solid organ or bone marrow transplantation, comparing their immune responses to those of healthy adults.

Other names

trivalent influenza vaccineTIVseasonal influenza vaccine